PEAK PROCESSING LIMITED — Share Issue/Capital Change 2021

Nov 18, 2021

==> picture [595 x 148] intentionally omitted <==

ASX Announcement | 19 November 2021 Althea Group Holdings (ASX:AGH)

Issuing of Securities

19 November 2021: Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH) (‘Althea’ or ‘the Company’) wishes to provide an update in relation to rights and securities which it has issued.

On 15 November 2021, the Company issued 5,705,598 fully paid ordinary shares in relation to the acquisition of Peak Processing Solutions (‘Peak’). The shares are the conversion of the exchangeable shares issued at the time Peak received its full suite of licenses from Health Canada, which were subject to a twelve-month restriction period before being able to be exercised.

Althea has also focused on building and retaining a strong executive management team with the skills, experience and commitment necessary to propel the Company toward its ultimate goal of becoming the market leader in the global medicinal cannabis industry. The Company has implemented a longterm incentive (performance) rights framework, which was approved by shareholders on 27 November 2019, and aims to reward participants for achieving organisational objectives and delivering shareholder value.

The Board has endorsed the issue of 1,366,881 rights that have been issued to executives and senior managers in relation to short-term incentives for FY21. These rights are subject to restrictions ranging from twelve to twenty-four months.

The Company also issued 352,131 rights to various key opinion leaders (healthcare professionals) for services rendered to Althea, in lieu of cash.

-ENDS-

Authorised by: Robert Meissner, Company Secretary

For further information, please contact:

Althea Media Enquiries Investor Relations Josh Fegan Dan Francome Jane Morgan CEO & Managing Director Media Relations Investor Relations Partner M: 1300 70 20 20 P: +613 9650 5096 M: +61 405 555 618 E: contact@althea.life E: dfrancome@althea.life E: jm@janemorganmanagement.com.au

Althea Group Holdings Limited (ASX:AGH)

Althea Group Holdings Ltd (ASX:AGH) is a global pharmaceutical company and supplier of medicinal cannabis. Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.

==> picture [596 x 92] intentionally omitted <==

==> picture [595 x 148] intentionally omitted <==

Althea currently operates within highly regulated medicinal cannabis markets including Australia, United Kingdom and Germany, with plans to expand into emerging markets throughout Asia and Europe.

To learn more, please visit: www.althea.life

==> picture [596 x 92] intentionally omitted <==